ly3437943 retatrutide triple agonist glp-1 gip glucagon in healthy participants in a phase 1 single ascending dose LY3437943, a novel triple GIP,

ly3437943 retatrutide triple agonist glp-1 gip glucagon

ly3437943 retatrutide triple agonist glp-1 gip glucagon in healthy participants in a phase 1 single ascending dose LY3437943, a novel triple GIP,

Name: ly3437943 retatrutide triple agonist glp-1 gip glucagon in healthy participants in a phase 1 single ascending dose LY3437943, a novel triple GIP,
Brand: wefit.es
SKU: 540672244
Price: 27.44 USD
Availability: InStock
Rating: 4.3726 (18 reviews)

SKU: 540672244

4.4

USD27.44 USD61.44

Pay in 4 interest-free payments of $6.86 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 10 - Aug 15

Description

Selank was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences and is based on the naturally occurring immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg, corresponding to residues 289-292 of the IgG heavy chain) with a C-terminal Pro-Gly-Pro extension derived from the proline-rich peptide family that enhances metabolic stability and CNS penetration